DK115349B - Fremgangsmåde til fremstilling af en som vaccine anvendelig, inaktiveret virussuspension, der indeholder et virus, som er isoleret fra in vitro dyrkede nyreceller fra en hundehvalp, der lider af rhinitis eller bronkopneumoni. - Google Patents

Fremgangsmåde til fremstilling af en som vaccine anvendelig, inaktiveret virussuspension, der indeholder et virus, som er isoleret fra in vitro dyrkede nyreceller fra en hundehvalp, der lider af rhinitis eller bronkopneumoni.

Info

Publication number
DK115349B
DK115349B DK593666A DK593666A DK115349B DK 115349 B DK115349 B DK 115349B DK 593666 A DK593666 A DK 593666A DK 593666 A DK593666 A DK 593666A DK 115349 B DK115349 B DK 115349B
Authority
DK
Denmark
Prior art keywords
bronchopneumonia
puppy
rhinitis
vaccine
suffering
Prior art date
Application number
DK593666A
Other languages
English (en)
Inventor
Ratuld Y De
G Werner
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of DK115349B publication Critical patent/DK115349B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK593666A 1965-11-17 1966-11-16 Fremgangsmåde til fremstilling af en som vaccine anvendelig, inaktiveret virussuspension, der indeholder et virus, som er isoleret fra in vitro dyrkede nyreceller fra en hundehvalp, der lider af rhinitis eller bronkopneumoni. DK115349B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR38768A FR1484638A (fr) 1965-11-17 1965-11-17 Procédé de culture et d'inactivation d'un nouveau virus

Publications (1)

Publication Number Publication Date
DK115349B true DK115349B (da) 1969-09-29

Family

ID=8592711

Family Applications (1)

Application Number Title Priority Date Filing Date
DK593666A DK115349B (da) 1965-11-17 1966-11-16 Fremgangsmåde til fremstilling af en som vaccine anvendelig, inaktiveret virussuspension, der indeholder et virus, som er isoleret fra in vitro dyrkede nyreceller fra en hundehvalp, der lider af rhinitis eller bronkopneumoni.

Country Status (7)

Country Link
US (1) US3462526A (da)
BE (1) BE689728A (da)
CH (1) CH470479A (da)
DE (1) DE1617756A1 (da)
DK (1) DK115349B (da)
FR (1) FR1484638A (da)
GB (1) GB1143996A (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
FR2368281A1 (fr) * 1976-04-26 1978-05-19 Cutter Lab Nouvelle culture cellulaire, son application a la preparation d'un vaccin antiviral et vaccin obtenu
US4112068A (en) * 1976-08-11 1978-09-05 Cutter Laboratories, Inc. Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom
US4225583A (en) * 1978-12-07 1980-09-30 Iowa State University Research Foundation, Inc. Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses
CN112574946B (zh) * 2020-12-28 2023-12-12 中国科学院昆明动物研究所 一种原代分离培养土狗多个组织来源的成纤维细胞及其永生化的构建方法

Also Published As

Publication number Publication date
DE1617756A1 (de) 1971-04-08
FR1484638A (fr) 1967-06-16
GB1143996A (en) 1969-02-26
US3462526A (en) 1969-08-19
CH470479A (fr) 1969-03-31
BE689728A (da) 1967-05-16

Similar Documents

Publication Publication Date Title
DK115349B (da) Fremgangsmåde til fremstilling af en som vaccine anvendelig, inaktiveret virussuspension, der indeholder et virus, som er isoleret fra in vitro dyrkede nyreceller fra en hundehvalp, der lider af rhinitis eller bronkopneumoni.
DK123238B (da) Analogifremgangsmåde til fremstilling af piperidinderivater eller salte deraf.
DK104193C (da) Fremgangsmåde til stabilisering af labile, antigene virusmaterialer.
DK96884C (da) Fremgangsmåde til fremstilling af indolderivater eller salte heraf.
DK102853C (da) Fremgangsmåde til fremstilling af benzensulfonylurinstoffer eller deres salte.
DK116129B (da) Fremgangsmåde til fremstilling af piperidinderivater eller salte deraf.
DK129468B (da) Fremgangsmåde til dyrkning af virus.
DK109505C (da) Apparat til inddrivning af stifter eller lignende organer i hårde vægmaterialer.
DK112312B (da) Fremgangsmåde til fremstilling af piperidinderivater eller salte deraf.
FI31218A (fi) Sängbotten, sits eller ryggstöd, som består av en ram och därvid eftergivande upphängda bärelement
DK92243C (da) Apparat til fremstilling af poser, som er forsynet med en eller flere lukkestrimler.
DK131992B (da) Analogifremgangsmåde til fremstilling af xanthenderivater eller syreadditionssalte og/eller kvaternære derivater deraf.
DK100515C (da) Fremgangsmåde til dyrkning af mund- og klovsyge-virus.
DK96933C (da) Fremgangsmåde til fremstilling af basiske indolderivater eller deres salte.
DK96740C (da) Fremgangsmåde til fremstilling af basiske indolderivater eller deres salte.
DK96643C (da) Fremgangsmåde til fremstilling af basiske indolderivater eller deres salte.
DK95879C (da) Fremgangsmåde til fremstilling af basiske indolderivater eller deres salte.
DK91225C (da) Fremgangsmåde til fremstilling af 3,5-diketopyrazolidinderivater eller deres salte.
DK111525B (da) Fremgangsmåde til fremstilling af monoalkylamino-propyliden-dibenzo-[b,e]-oksepin- eller -tiepinderivater eller deres hydrohalogenider.
DK105527C (da) Fremgangsmåde til fremstilling af benzensulfonylurinstoffer eller deres salte.
DK96560C (da) Fremgangsmåde til fremstilling af i m-stilling i en fenylgruppe substituerede difenylaminderivater eller salte deraf.
DK99701C (da) Fremgangsmåde til fremstilling af mund- og klovsyge-koncentratvacciner.
DK90093C (da) Fremgangsmåde til fremstilling af 3,5-diketopyrazolidinderivater eller salte heraf.
DK88750C (da) Fremgangsmåde til fremstilling af 3,5-diketo-pyrazolidinderivater eller salte heraf.
DK88605C (da) Fremgangsmåde til fremstilling af 3,5-diketopyrazolidinderivater eller salte heraf.